We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About BrainScope Company Stock

Invest in or calculate the value of your shares in BrainScope Company or other pre-IPO companies through EquityZen's platform.

Get Started

BrainScope Company Stock (BRSC)

Brainscope is a medical neurotechnology company that improves brain health.

About BrainScope Company Stock

Founded

1990

Headquarters

Bethesda, MD, US

Industries

Software, Artificial Intelligence, Data and Analytics

Brainscope is a medical neurotechnology company that improves brain health. It develops a new generation of hand-held, simple-to-use, non-invasive instruments to aid medical professionals in rapidly, accurately, and objectively assessing brain function at the initial point of care. BrainScope devices in development are based on a revolutionary and proprietary technology platform, which integrates databases of brainwave recordings with advanced developments in Digital Signal Processing (DSP), sophisticated linear and non-linear algorithms, miniaturized hardware, and disposable headset sensors. It also provides objective, diagnostic insights that enable better patient care. The company’s innovative BrainScope One system is the first and only portable, EEG-based, radiation-free platform that empowers physicians to quickly make accurate head injury assessments. It was founded in 2010 and is headquartered in Bethesda, Maryland.

BrainScope Company Press Mentions

Stay in the know about the latest news on BrainScope Company

BrainScope Company Management

Leadership team at BrainScope Company

Chief Financial Officer

Laurie Silver

Board Member

Ralph Terkowitz

Locked Features

Join now and verify your accreditation status to gain access to:

  • BrainScope Company current valuation
  • BrainScope Company stock price
  • Available deals in BrainScope Company and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading BrainScope Company Stock

How to invest in BrainScope Company stock?

Accredited investors can buy pre-IPO stock in companies like BrainScope Company through EquityZen funds. These investments are made available by existing BrainScope Company shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell BrainScope Company stock?

Shareholders can sell their BrainScope Company stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."